Giovanna Liguori
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Giovanna Liguori has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Vittorio Sambri
Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy
2 shared publications - Alba Carola Finarelli
Regional Health Authority; Bologna, Italy
1 shared publication - Bianca Maria Borrini
Regional Health Authority; Bologna, Italy
1 shared publication - Francesca Cavrini
Operative Unit of Clinical Microbiology, Regional Reference Centre for Microbiological Emergencies, S. Orsola-Malpighi University Hospital, Bologna 40138, Italy
1 shared publication - Francesca Cavrini
Unit of Clinical Microbiology; S. Orsola-Malpighi University Hospital; Bologna, Italy
1 shared publication - Gabriella Frasca
Public Health Unit Emilia-Romagna Region, Viale Aldo Moro 21, 40127 Bologna, Italy
1 shared publication
Latest Publications
- Open Access
- 30 December 2013
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 10 (3) , 671-676
Impact of meningococcal C conjugate vaccination campaign in Emilia-Romagna, Italy
The incidence of reported meningococcal disease in Italy is among the lowest in Europe. The trend of the disease was increasing up to 2005 and then declined after the gradual introduction of a universal Men C vaccination program in 17/21 Italian regions. Since 2006, in Emilia-Romagna region vaccination against Neisseria meningitidis serogroup C was actively offered free of charge in a single dose to the age groups 12–15 months and 14–15 years, in addition to people with defined epidemiological risk. Our aim was to measure the impact of vaccination on the incidence of meningococcal disease caused by different serogroups among the population of Emilia Romagna Region, Northern Italy (approximately 4.5 million inhabitants) subdivided by age. Using surveillance data, we computed the incidence rates of Neisseria meninigitidis related invasive disease per 100.000 inhabitants for the years 2000 to 2012. In addition, the percentage change in incidence and the mortality rates were calculated. Results indicate a 70.1% decrease in the incidence of meningococcus C-related invasive disease after the introduction of MenC universal vaccination. No case of serogroup C related infection was observed since 2006 in children aged 1–4 years. These findings suggest that the single-dose vaccination strategy against serogroup C N.meningitidis targeted to the age groups 12–15 months and 14–15 years was effective in the Emilia-Romagna population. However, the occurrence of two cases of meningiditis in a 5-month child and in a 9-years child suggests caution and careful consideration in surveillance for the next years.
- 30 December 2013
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 10 (3) , 671-676
Open AccessImpact of meningococcal C conjugate vaccination campaign in Emilia-Romagna, Italy
The incidence of reported meningococcal disease in Italy is among the lowest in Europe. The trend of the disease was increasing up to 2005 and then declined after the gradual introduction of a universal Men C vaccination program in 17/21 Italian regions. Since 2006, in Emilia-Romagna region vaccination against Neisseria meningitidis serogroup C was actively offered free of charge in a single dose to the age groups 12–15 months and 14–15 years, in addition to people with defined epidemiological risk. Our aim was to measure the impact of vaccination on the incidence of meningococcal disease caused by different serogroups among the population of Emilia Romagna Region, Northern Italy (approximately 4.5 million inhabitants) subdivided by age. Using surveillance data, we computed the incidence rates of Neisseria meninigitidis related invasive disease per 100.000 inhabitants for the years 2000 to 2012. In addition, the percentage change in incidence and the mortality rates were calculated. Results indicate a 70.1% decrease in the incidence of meningococcus C-related invasive disease after the introduction of MenC universal vaccination. No case of serogroup C related infection was observed since 2006 in children aged 1–4 years. These findings suggest that the single-dose vaccination strategy against serogroup C N.meningitidis targeted to the age groups 12–15 months and 14–15 years was effective in the Emilia-Romagna population. However, the occurrence of two cases of meningiditis in a 5-month child and in a 9-years child suggests caution and careful consideration in surveillance for the next years.
- 1 July 2007
- Vol. 30 (3) , 253-4
Late-onset group B streptococcal disease by infected mother's milk detected by polymerase chain reaction.
Late-onset Group B streptococcal (GBS) disease is a cause of illness, death and neurological sequelae in infancy. The epidemiology and pathogenesis of late-onset GBS disease is poorly defined. Infected breast-milk has been suggested as a source of postnatal infection and invasive disease. We describe a late-onset GBS disease by infected mother's milk in a term newborn in which the detection of GBS in neonatal bloodstream (confirmed by culture) and in the mother's milk was performed by PCR.
- 1 July 2007
- Vol. 30 (3) , 253-4
Late-onset group B streptococcal disease by infected mother's milk detected by polymerase chain reaction.
Late-onset Group B streptococcal (GBS) disease is a cause of illness, death and neurological sequelae in infancy. The epidemiology and pathogenesis of late-onset GBS disease is poorly defined. Infected breast-milk has been suggested as a source of postnatal infection and invasive disease. We describe a late-onset GBS disease by infected mother's milk in a term newborn in which the detection of GBS in neonatal bloodstream (confirmed by culture) and in the mother's milk was performed by PCR.